Systematic review and meta-analysis of 16 studies of eltrombopag for thrombocytopenia after allogeneic HCT: pooled platelet response rates were 72% (>30 x10^9/L) and 56% (>50 x10^9/L); pooled overall survival 68%.
Meta-analysisn = 16 studies
Kumar et al. Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis